Toggle Main Menu Toggle Search

Open Access padlockePrints

Cutaneous T cell lymphoma atlas reveals malignant TH2 cells supported by a B cell-rich tumor microenvironment

Lookup NU author(s): Dr Beth Poyner, Emily Stephenson, Dr Louis Gardner, Dr Bayanne Olabi, Dr Hudaa Gopee, Marta Chroscik, Effie Kritikaki, Justin Engelbert, Issac Goh, Dr Win Tun, Dr Gary Reynolds, Chloe Admane, Dr Laura JardineORCiD, Dr Keir Pickard, Jenny Lumley, Dr Philip Hampton, Dave Horsfall, Daniela Basurto Lozada, Louise Grimble, Dr Christopher Bacon, Dr Sophie Weatherhead, Professor Nick ReynoldsORCiD, Professor Muzlifah Haniffa

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2024. Cutaneous T cell lymphoma (CTCL) is a potentially fatal clonal malignancy of T cells primarily affecting the skin. The most common form of CTCL, mycosis fungoides, can be difficult to diagnose, resulting in treatment delay. We performed single-cell and spatial transcriptomics analysis of skin from patients with mycosis fungoides-type CTCL and an integrated comparative analysis with human skin cell atlas datasets from healthy and inflamed skin. We revealed the co-optation of T helper 2 (TH2) cell-immune gene programs by malignant CTCL cells and modeling of the tumor microenvironment to support their survival. We identified MHC-II+ fibroblasts and dendritic cells that can maintain TH2 cell-like tumor cells. CTCL tumor cells are spatially associated with B cells, forming tertiary lymphoid structure-like aggregates. Finally, we validated the enrichment of B cells in CTCL and its association with disease progression across three independent patient cohorts. Our findings provide diagnostic aids, potential biomarkers for disease staging and therapeutic strategies for CTCL.


Publication metadata

Author(s): Li R, Strobl J, Poyner EFM, Balbaa A, Torabi F, Mazin PV, Chipampe N-J, Stephenson E, Ramirez-Suastegi C, Shanmugiah VBM, Gardner L, Olabi B, Coulthard R, Botting RA, Zila N, Prigmore E, Gopee NH, Chroscik MA, Kritikaki E, Engelbert J, Goh I, Chan HM, Johnson HF, Ellis J, Rowe V, Tun W, Reynolds G, Yang D, Foster AR, Gambardella L, Winheim E, Admane C, Rumney B, Steele L, Jardine L, Nenonen J, Pickard K, Lumley J, Hampton P, Hu S, Liu F, Liu X, Horsfall D, Basurto-Lozada D, Grimble L, Bacon CM, Weatherhead SC, Brauner H, Wang Y, Bai F, Reynolds NJ, Allen JE, Jonak C, Brunner PM, Teichmann SA, Haniffa M

Publication type: Article

Publication status: Published

Journal: Nature Immunology

Year: 2024

Volume: 25

Pages: 2320–2330

Print publication date: 01/12/2024

Online publication date: 18/11/2024

Acceptance date: 11/10/2024

Date deposited: 04/12/2024

ISSN (print): 1529-2908

ISSN (electronic): 1529-2916

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41590-024-02018-1

DOI: 10.1038/s41590-024-02018-1

Data Access Statement: There are no restrictions on data availability for newly generated data presented in the present study. FASTQ files of all raw sequencing data from the present study have been deposited at EMBL-EBI ArrayEx press and are made publicly available at accessions E-MTAB-14559, E-MTAB-12303 and E-MTAB-13614. Previously published scRNA-seq datasets are available in the Genome Sequence Archive for humans (accession HRA000166), the NCBI BioProject database (accession HRA000166), ArrayExpress (accession E-MTAB-8142) and the GEO database (accession GSE173205). Previously published bulk RNA-seq datasets are available in the GEO database under accessions GSE168508 and GSE121212. Scanpy h5ad objects for CTCL, CCL plus skin cell atlas and Visium data are available for download and can be explored on an online web portal: https://collections.cellatlas.io/ctcl. The code generated during the present study is available at GitHub: https://github.com/ruoyan-li/Cutaneous-T-cell-lymphoma-study


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
British Heart Foundation
European Research Council Consolidator (grant 646794)
NIHR
Wellcome Trust (grants 206194 and 108413/A/15/D)
WT107931/Z/15/Z
WT211276/Z/18/Z
Wellcome Trust (grant WT206194)
Wellcome Trust (grants 203151/Z/16/Z and 203151/A/16/Z)

Share